ARTICLE | Company News
J&J submits carisbamate NDA
October 25, 2008 12:58 AM UTC
Johnson & Johnson (NYSE:JNJ) submitted an NDA to FDA for Comfyde carisbamate as an adjunctive treatment for partial onset seizures in epilepsy patients 16 and older. J&J received worldwide rights to t...